Literature DB >> 24238296

Ocular perfusion pressure in glaucoma.

Vital P Costa1, Alon Harris, Douglas Anderson, Richard Stodtmeister, Fernanda Cremasco, Helene Kergoat, John Lovasik, Ingborg Stalmans, Oliver Zeitz, Ines Lanzl, Konstantin Gugleta, Leopold Schmetterer.   

Abstract

This review article discusses the relationship between ocular perfusion pressure and glaucoma, including its definition, factors that influence its calculation and epidemiological studies investigating the influence of ocular perfusion pressure on the prevalence, incidence and progression of glaucoma. We also list the possible mechanisms behind this association, and discuss whether it is secondary to changes in intraocular pressure, blood pressure or both. Finally, we describe the circadian variation of ocular perfusion pressure and the effects of systemic and topical medications on it. We believe that the balance between IOP and BP, influenced by the autoregulatory capacity of the eye, is part of what determines whether an individual will develop optic nerve damage. However, prospective, longitudinal studies are needed to better define the role of ocular perfusion pressure in the development and progression of glaucoma.
© 2013 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  blood pressure; glaucoma risk factors; ocular perfusion pressure; optic nerve blood flow

Mesh:

Year:  2013        PMID: 24238296     DOI: 10.1111/aos.12298

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  59 in total

1.  Head-down Posture in Glaucoma Suspects Induces Changes in IOP, Systemic Pressure, and PERG That Predict Future Loss of Optic Nerve Tissue.

Authors:  Vittorio Porciatti; William J Feuer; Pedro Monsalve; Giacinto Triolo; Luis Vazquez; John McSoley; Lori M Ventura
Journal:  J Glaucoma       Date:  2017-05       Impact factor: 2.503

2.  Does steep Trendelenburg positioning effect the ocular hemodynamics and intraocular pressure in patients undergoing robotic cystectomy and robotic prostatectomy?

Authors:  Muhammet Fuat Ozcan; Ziya Akbulut; Canan Gurdal; Sinan Tan; Yelda Yildiz; Serdar Bayraktar; Ayse Nur Ozcan; Kemal Ener; Serkan Altinova; Muhammed Ersagun Arslan; Mevlana Derya Balbay
Journal:  Int Urol Nephrol       Date:  2016-11-01       Impact factor: 2.370

Review 3.  Pharmacotherapy of glaucoma.

Authors:  Doreen Schmidl; Leopold Schmetterer; Gerhard Garhöfer; Alina Popa-Cherecheanu
Journal:  J Ocul Pharmacol Ther       Date:  2015-01-14       Impact factor: 2.671

4.  Twenty-four-hour intraocular pressure and ocular perfusion pressure characteristics in newly diagnosed patients with normal tension glaucoma.

Authors:  L Quaranta; A Katsanos; I Riva; A Dastiridou; F Oddone; G Roberti; A G P Konstas
Journal:  Eye (Lond)       Date:  2016-07-29       Impact factor: 3.775

5.  Nocturnal systemic hypotension increases the risk of glaucoma progression.

Authors:  Mary E Charlson; Carlos Gustavo de Moraes; Alissa Link; Martin T Wells; Gregory Harmon; Janey C Peterson; Robert Ritch; Jeffrey M Liebmann
Journal:  Ophthalmology       Date:  2014-05-25       Impact factor: 12.079

6.  Effect of surgical intraocular pressure lowering on retinal structures - nerve fibre layer, foveal avascular zone, peripapillary and macular vessel density: 1 year results.

Authors:  Tun Wang Ch'ng; Kevin Gillmann; Kirsten Hoskens; Harsha L Rao; André Mermoud; Kaweh Mansouri
Journal:  Eye (Lond)       Date:  2019-08-13       Impact factor: 3.775

7.  Ocular Perfusion Pressure vs Estimated Trans-Lamina Cribrosa Pressure Difference in Glaucoma: The Central India Eye and Medical Study (An American Ophthalmological Society Thesis).

Authors:  Jost B Jonas; Ningli Wang; Vinay Nangia
Journal:  Trans Am Ophthalmol Soc       Date:  2015

Review 8.  Prostaglandin analogues and nitric oxide contribution in the treatment of ocular hypertension and glaucoma.

Authors:  Francesco Impagnatiello; Elena Bastia; Nicoletta Almirante; Stefania Brambilla; Brigitte Duquesroix; Angela C Kothe; Michael V W Bergamini
Journal:  Br J Pharmacol       Date:  2018-05-24       Impact factor: 8.739

9.  The African Descent and Glaucoma Evaluation Study (ADAGES): predictors of visual field damage in glaucoma suspects.

Authors:  Naira Khachatryan; Felipe A Medeiros; Lucie Sharpsten; Christopher Bowd; Pamela A Sample; Jeffrey M Liebmann; Christopher A Girkin; Robert N Weinreb; Atsuya Miki; Na'ama Hammel; Linda M Zangwill
Journal:  Am J Ophthalmol       Date:  2015-01-15       Impact factor: 5.258

Review 10.  Biomarkers and surrogate endpoints in glaucoma clinical trials.

Authors:  Felipe A Medeiros
Journal:  Br J Ophthalmol       Date:  2014-07-17       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.